Atrial Fibrillation
Conditions
Interventions
Non-exposed group:None
Exposure group:None
Sponsors
Qilu Hospital, Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged between 18 and 75 years, inclusive. 2. Objective evidence of paroxysmal or persistent AF is documented by 12-lead ECG or 24-hour Holter monitoring or other validated diagnostic methods (e.g., implantable loop recorder, tilt-test). 3. Capable of understanding and signing the informed consent form and complying with protocol-required treatment and follow-up.
Exclusion criteria
Exclusion criteria: 1. Competing arrhythmic substrates (AT/VT/VF/advanced AV block) or secondary AF. 2. Structural heart disease, including LA thrombus or diameter >50mm, LVEF 3×ULN, eGFR <30ml / (min*1.73 m2)), Active malignancy, or dementia. 4. Protocol-defined prohibitions (concurrent trials, device allergies). 5. Logistical constraints (pregnancy, <1-year survival prognosis). 6. Other circumstances where the investigator determines that the patient is not suitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AF recurrence;Diagnosis-to-Treatment time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of composite endpoints( including: CV mortality, heart failure(HF),dementia and stroke) within 2-year follow-up;Incidence of composite endpoints( including: CV mortality, heart failure(HF),dementia and stroke) within 2-year follow-up; | — |
Countries
CHINA
Contacts
Public ContactYang Ruixue
Qilu Hospital, Shandong University
Outcome results
None listed